BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ganghammer S, Gutjahr J, Hutterer E, Krenn PW, Pucher S, Zelle-Rieser C, Jöhrer K, Wijtmans M, Leurs R, Smit MJ, Gattei V, Greil R, Hartmann TN. Combined CXCR3/CXCR4 measurements are of high prognostic value in chronic lymphocytic leukemia due to negative co-operativity of the receptors. Haematologica 2016;101:e99-102. [PMID: 26589908 DOI: 10.3324/haematol.2015.133470] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Virdis P, Migheli R, Bordoni V, Fiorentino FP, Sanna L, Marchesi I, Pintore G, Galleri G, Muroni MR, Bagella L, Fozza C, De Miglio MR, Podda L. Clarifying the molecular mechanism of tomentosin‑induced antiproliferative and proapoptotic effects in human multiple myeloma via gene expression profile and genetic interaction network analysis. Int J Mol Med 2021;48:213. [PMID: 34643251 DOI: 10.3892/ijmm.2021.5046] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Lewis R, Maurer HC, Singh N, Gonzalez-Menendez I, Wirth M, Schick M, Zhang L, Isaakidis K, Scherger AK, Schulze V, Lu J, Zenz T, Steiger K, Rad R, Quintanilla-Martinez L, Espeli M, Balabanian K, Keller U, Habringer S. CXCR4 hyperactivation cooperates with TCL1 in CLL development and aggressiveness. Leukemia 2021. [PMID: 34363012 DOI: 10.1038/s41375-021-01376-1] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Feusier JE, Madsen MJ, Avery BJ, Williams JA, Stephens DM, Hu B, Osman AEG, Glenn MJ, Camp NJ. Shared genomic segment analysis in a large high-risk chronic lymphocytic leukemia pedigree implicates CXCR4 in inherited risk. J Transl Genet Genom 2021;5:189-99. [PMID: 34368645 DOI: 10.20517/jtgg.2021.05] [Reference Citation Analysis]
4 Russo E, Santoni A, Bernardini G. Tumor inhibition or tumor promotion? The duplicity of CXCR3 in cancer. J Leukoc Biol 2020;108:673-85. [PMID: 32745326 DOI: 10.1002/JLB.5MR0320-205R] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
5 Mesaros O, Jimbu L, Neaga A, Popescu C, Berceanu I, Tomuleasa C, Fetica B, Zdrenghea M. Macrophage Polarization in Chronic Lymphocytic Leukemia: Nurse-Like Cells Are the Caretakers of Leukemic Cells. Biomedicines 2020;8:E516. [PMID: 33228048 DOI: 10.3390/biomedicines8110516] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
6 Dubois N, Crompot E, Meuleman N, Bron D, Lagneaux L, Stamatopoulos B. Importance of Crosstalk Between Chronic Lymphocytic Leukemia Cells and the Stromal Microenvironment: Direct Contact, Soluble Factors, and Extracellular Vesicles. Front Oncol 2020;10:1422. [PMID: 32974152 DOI: 10.3389/fonc.2020.01422] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
7 Mayerhoefer ME, Haug A, Jäger U, Pichler V, Pfaff S, Wester HJ, Hacker M, Kazianka L, Staber PB. In Human Visualization of Ibrutinib-Induced CLL Compartment Shift. Cancer Immunol Res 2020;8:984-9. [PMID: 32580942 DOI: 10.1158/2326-6066.CIR-19-0880] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Manukyan G, Papajik T, Mikulkova Z, Urbanova R, Kraiczova VS, Savara J, Kudelka M, Turcsanyi P, Kriegova E. High CXCR3 on Leukemic Cells Distinguishes IgHV mut from IgHV unmut in Chronic Lymphocytic Leukemia: Evidence from CD5high and CD5low Clones. J Immunol Res 2020;2020:7084268. [PMID: 32802894 DOI: 10.1155/2020/7084268] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Bonanni V, Antonangeli F, Santoni A, Bernardini G. Targeting of CXCR3 improves anti-myeloma efficacy of adoptively transferred activated natural killer cells. J Immunother Cancer 2019;7:290. [PMID: 31699153 DOI: 10.1186/s40425-019-0751-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
10 Mayerhoefer ME, Archibald SJ, Messiou C, Staudenherz A, Berzaczy D, Schöder H. MRI and PET/MRI in hematologic malignancies. J Magn Reson Imaging 2020;51:1325-35. [PMID: 31260155 DOI: 10.1002/jmri.26848] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
11 Chen F, Yuan J, Yan H, Liu H, Yin S. Chemokine Receptor CXCR3 Correlates with Decreased M2 Macrophage Infiltration and Favorable Prognosis in Gastric Cancer. Biomed Res Int 2019;2019:6832867. [PMID: 31240220 DOI: 10.1155/2019/6832867] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
12 Patrussi L, Capitani N, Baldari CT. Abnormalities in chemokine receptor recycling in chronic lymphocytic leukemia. Cell Mol Life Sci 2019;76:3249-61. [PMID: 30830241 DOI: 10.1007/s00018-019-03058-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
13 Aguilera-montilla N, Bailón E, Uceda-castro R, Ugarte-berzal E, Santos A, Gutiérrez-gonzález A, Pérez-sánchez C, Van den Steen PE, Opdenakker G, García-marco JA, García-pardo A. MMP-9 affects gene expression in chronic lymphocytic leukemia revealing CD99 as an MMP-9 target and a novel partner in malignant cell migration/arrest. Oncogene 2019;38:4605-19. [DOI: 10.1038/s41388-019-0744-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
14 Redondo-Muñoz J, García-Pardo A, Teixidó J. Molecular Players in Hematologic Tumor Cell Trafficking. Front Immunol 2019;10:156. [PMID: 30787933 DOI: 10.3389/fimmu.2019.00156] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 6.7] [Reference Citation Analysis]
15 Azoulay D, Herishanu Y, Shapiro M, Brandshaft Y, Suriu C, Akria L, Braester A. Elevated serum BDNF levels are associated with favorable outcome in CLL patients: Possible link to CXCR4 downregulation. Experimental Hematology 2018;63:17-21.e1. [DOI: 10.1016/j.exphem.2018.04.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
16 Mayerhoefer ME, Jaeger U, Staber P, Raderer M, Wadsak W, Pfaff S, Kornauth C, Senn D, Weber M, Wester H, Skrabs C, Haug A. [68Ga]Ga-Pentixafor PET/MRI for CXCR4 Imaging of Chronic Lymphocytic Leukemia: Preliminary Results. Invest Radiol 2018;53:403-8. [DOI: 10.1097/rli.0000000000000469] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 5.3] [Reference Citation Analysis]
17 Teixidó J, Martínez-Moreno M, Díaz-Martínez M, Sevilla-Movilla S. The good and bad faces of the CXCR4 chemokine receptor. Int J Biochem Cell Biol 2018;95:121-31. [PMID: 29288743 DOI: 10.1016/j.biocel.2017.12.018] [Cited by in Crossref: 34] [Cited by in F6Publishing: 45] [Article Influence: 6.8] [Reference Citation Analysis]
18 Nugent A, Proia RL. The role of G protein-coupled receptors in lymphoid malignancies. Cell Signal 2017;39:95-107. [PMID: 28802842 DOI: 10.1016/j.cellsig.2017.08.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
19 Haerzschel A, Catusse J, Hutterer E, Paunovic M, Zirlik K, Eibel H, Krenn PW, Hartmann TN, Burger M. BCR and chemokine responses upon anti-IgM and anti-IgD stimulation in chronic lymphocytic leukaemia. Ann Hematol 2016;95:1979-88. [PMID: 27542958 DOI: 10.1007/s00277-016-2788-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]